Livzon Pharmaceutical Group Overview

  • Founded
  • 1985

Founded
  • Status
  • Public

  • Employees
  • 8,693

Employees
  • Stock Symbol
  • 000513

Stock Symbol
  • Investments
  • 15

  • Share Price
  • $5.05

  • (As of Tuesday Closing)

Livzon Pharmaceutical Group General Information

Description

Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio primarily comprises western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. The Company distributes its products within domestic markets and to overseas markets. The company operates in a single reportable segment that is pharmaceutical manufacturing.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
SHE
Primary Office
  • No.132, Guihua Road North
  • Gongbei, Zhuhai
  • Guangdong, 519020
  • China
+86 175 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Livzon Pharmaceutical Group Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.05 $5.23 $4.04 - $6.85 $4.32B 936M 10.9M $0.30

Livzon Pharmaceutical Group Financials Summary

In Thousands,
USD
TTM 30-Sep-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 2,683,746 4,282,796 4,224,803 3,093,834
Revenue 1,858,630 1,868,316 1,522,797 1,358,203
EBITDA 306,062 404,636 395,663 273,962
Net Income 279,149 274,998 248,228 188,559
Total Assets 3,307,588 3,509,816 3,151,672 2,569,241
Total Debt 492,475 422,709 295,395 194,495
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Livzon Pharmaceutical Group Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's
Drug Discovery
Guangdong, China
8,693 As of 2022

00000

o consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat
0000 000000000
Mumbai, India
00000 As of 0000
00000000

000000

rit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidata
000000000000000
Lagos, Nigeria
00 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Livzon Pharmaceutical Group Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cipla Corporation Mumbai, India 00000 00000000
000000000000000 00 Corporation Lagos, Nigeria 00
0000000 0000000000 Corporation Ahmedabad, India 00000 0000 00000000000 0000
000000000000000 Corporation Brentford, United Kingdom 00000 000000000
000000 Formerly PE-Backed Bengaluru, India 00000 000.00 00000000 000.00
You’re viewing 5 of 17 competitors. Get the full list »

Livzon Pharmaceutical Group Patents

Livzon Pharmaceutical Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3811941-A1 Pharmaceutical composition containing ilaprazole or salt thereof and preparation method therefor Pending 22-Jun-2018 00000000000
US-20210260046-A1 Pharmaceutical composition containing ilaprazole or salt thereof and preparation method therefor Pending 22-Jun-2018 00000000000
EP-3811941-A4 Pharmaceutical composition containing ilaprazole or salt thereof and preparation method therefor Pending 22-Jun-2018 00000000000 0
EP-3607940-A4 Aripiprazole sustained-release microsphere and preparation method therefor Pending 16-May-2018 0000000000
EP-3607940-A1 Aripiprazole sustained-release microsphere and preparation method therefor Pending 16-May-2018 A61K9/1647
To view Livzon Pharmaceutical Group’s complete patent history, request access »

Livzon Pharmaceutical Group Executive Team (4)

Name Title Board Seat Contact Info
Yanggang Tang Board Member & President
YuCai Peng Ph.D Vice President, Research & Technical Development
Desheng Tao Vice Chairman
Guoxiang Xu Vice Chairman & Vice President
To view Livzon Pharmaceutical Group’s complete executive team members history, request access »

Livzon Pharmaceutical Group Board Members (11)

Name Representing Role Since
000000 000 Self Chairman & Board Member 000 0000
0000000 000 Livzon Pharmaceutical Group Vice Chairman 000 0000
00000000 00 Livzon Pharmaceutical Group Vice Chairman & Vice President 000 0000
000 000 Livzon Pharmaceutical Group Board Member 000 0000
000 00 0000 Livzon Pharmaceutical Group Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Livzon Pharmaceutical Group Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Livzon Pharmaceutical Group Investments (15)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 21-Sep-2022 0000 0000 Drug Discovery
0000 00000000 04-Jan-2022 00000 0000 000.00 Drug Discovery
00000 0000000 31-Aug-2021 00000 0000 0000 Drug Discovery
0000000 00000 01-Mar-2021 00000 0000 0000 Drug Discovery
Elicio Therapeutics 17-Feb-2021 Later Stage VC 00000 Drug Discovery
You’re viewing 5 of 15 investments. Get the full list »

Livzon Pharmaceutical Group Subsidiaries (1)

Company Name Industry Location Founded
000000 00000000 Drug Discovery Zhuhai, China 0000
To view Livzon Pharmaceutical Group’s complete subsidiaries history, request access »

Livzon Pharmaceutical Group Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 000 08-Jan-2020 0000 00000 Completed
  • 3 buyers
EPIRUS Biopharmaceuticals 16-Apr-2014 Early Stage VC 0000 Completed
  • 11 buyers
To view Livzon Pharmaceutical Group’s complete exits history, request access »